Epidemiological Trends and Updates on Esophageal Cancer-Esopageal Cancer Magazine Publishing Limited

¹ Cancer Hospital, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, Henan 471000, P. R. China.
² Henan Key Laboratory of Cancer Epigenetics, Luoyang, Henan 471000, China.

Keywords:

Esophageal cancer ; Epidemiology ; Changing trends ; Mortality

CLC:

DOI:

Abstract:

Esophageal cancer (EC) is the eleventh most common type of cancer worldwide and constitutes the seventh leading cause of cancer deaths, with significant variability in its incidence among different regions. In China, EC ranks among the leading malignancies in the number of new cases and mortality, with significant disparities observed across gender and between urban and rural populations. However, with the development of China's health care, early detection and prevention, the incidence of EC in China has shown a decreasing trend, demonstrating the effectiveness of current preventive and curative measures in reducing the disease burden and improving public health. Here, we focus on the latest data and developments in the epidemiology of EC.

References:

[1] Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-263. doi:10.3322/caac.21834
[2] Sung, H. Ferlay, J. Siegel, R. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. , 2021 Feb 4.
[3] Wang YX, Pan Kaifeng, Li Wenqing. Interpretation of the Global Cancer Statistics Report 2022 [J]. Journal of Multidisciplinary Cancer Management (Electronic Version), 2024, 10(03): 1-16.
[4] International Agency for Research on Cancer. IARC Biennial Report 2020-2021[J]. Lyon: International Agency for Research on Cancer, 2021.
[5] Businello G, Parente P, Mastracci L, et al. The pathologic and molecular landscape of esophageal squamous cell carcinogenesis. cancers (Basel). 2020;12(8).
[6] Waters JK, Reznik SI. Update on Management of Squamous Cell EC. Curr Oncol Rep. 2022;24(3):375-385. doi:10.1007/s11912-021-01153-4
[7] Qi L, Sun M, Liu W, Zhang X, Yu Y, Tian Z, Ni Z, Zheng R, Li Y. Global EC epidemiology in 2022 and predictions for 2050: A comprehensive analysis and projections based on GLOBOCAN data. Chin Med J (Engl). 2024 Dec 20;137(24):3108-3116.
[8] Menya D, Maina SK, Kibosia C, Kigen N, Oduor M, Some F, et al. Dental fluorosis and oral health in the African Esophageal Cancer Corridor: Findings from the Kenya ESCCAPE case-control study and a pan-African perspective. Int J Cancer 2019;145:99–109. doi:10.1002/ijc.32086.
[9] Ng CS, Ong XJ, Au M, Lau YH, Kwok HHY, Quan J. ALDH2 polymorphism, alcohol intake and the attributable burden of cancer in East Asia: Systematic review, meta-analysis, and modeling study. Ann Epidemiol 2023;85:113–120.e20. doi: 10.1016/j.annepidem.2023.05.013.
[10] Simba H, Menya D, Mmbaga BT, Dzamalala C, Finch P, Mlombe Y, et al. The contribution of smoking and smokeless tobacco to oesophageal squamous cell carcinoma risk in the African oesophageal cancer corridor: Results from the ESCCAPE multicentre case-control studies. Int J Cancer 2023;152:2269–2282. doi:10.1002/ijc.34458.
[11] Sewram V, Sitas F, O’Connell D, Myers J. Diet and esophageal cancer risk in the Eastern Cape Province of South Africa. Nutr Cancer 2014;66:791–799. doi: 10.1080/01635581.2014.916321.
[12] Jaskiewicz KJ. Oesophageal carcinoma: Cytopathology and nutritional aspects in aetiology. Anticancer Res 1989;9:1847–1852.
[13] Pink RC, Bailey TA, Iputo JE, Sammon AM, Woodman AC, Carter DR. Molecular basis for maize as a risk factor for esophageal cancer in a South African population via a prostaglandin E2 positive feedback mechanism. Nutr Cancer 2011;63:714–721. doi:10.1080/01635581.2011.570893.
[14] Mlombe YB, Rosenberg NE, Wolf LL, Dzamalala CP, Chalulu K,Chisi J, et al. Environmental risk factors for oesophageal cancer in Malawi: A case-control study. Malawi Med J 2015;27:88–92. doi:10.4314/mmj.v27i3.3.
[15] Geßner AL, Borkowetz A, Wilhelm TJ, Ludzu E, Baier M, Mastala Y, et al. Risk factors for esophageal cancer in a high-incidence area of Malawi. Cancer Causes Control 2021;32:1347–1354. doi:10.1007/s10552-021-01482-6.
[16] Masukume G, Mmbaga BT, Dzamalala CP, Mlombe YB, Finch P,Nyakunga-Maro G, et al. A very-hot food and beverage thermal exposure index and esophageal cancer risk in Malawi and Tanzania: findings from the ESCCAPE case-control studies. Br J Cancer 2022;127:1106–1115. doi: 10.1038/s41416-022-01890-8.
[17] Teng Yi, Zhang Xiaodan, Xia Changfa, et al. Comparative and Predictive Analysis of Cancer Incidence, Mortality and Prevalence in China and Globally: Interpretation of GLOBOCAN 2022 Data [J]. Chinese Journal of Cancer Prevention and Treatment, 2024, 31(23): 1413-1420. DOI: 10.16073/j.cnki.cjcpt.2024.23.01.
[18] Yao Yifei, Sun Kexin, Zheng Rongshou. Interpretation of the "Global Cancer Statistics Report 2022": Comparison between China and the World [J]. Chinese Journal of Bases and Clinics in General Surgery, 2024, 31(07): 769-780.
[19] Zheng RS, Chen Ru, Han Bingfeng, et al. Analysis of the Epidemiology of Malignant Tumors in China in 2022 [J]. Chinese Journal of Oncology, 2024, 46(03): 221-231. DOI: 10.3760/cma.j.cn112152-20240119-00035.
[20] Song S, Lei Lin, Liu Han, et al. Disease Burden of EC in Chinese Population: Summary and Analysis of Multiple Data Sources [J]. Chinese Journal of Cancer Prevention and Treatment, 2023, 30(15): 887-896.
[21] Zheng RS, Zhang S, Sun KX, et al. Analysis of the Epidemiology of Malignant Tumors in China in 2016 [J]. Monitoring and Trends, 2023, 45(3): 212-220.
[22] Zhou Jiachen, Zheng Rongshou, Wang Shaoming, et al. Comparison of the Burden of Major Digestive Tract Tumors in China and Some Countries in the World in 2020 [J]. Journal of Multidisciplinary Cancer Management (Electronic Version), 2021, 7(2): 26-32.
[23] van den Brandt PA. The impact of a healthy lifestyle on the risk of esophageal and gastric cancer subtypes. Eur J Epidemiol 2022;37:931–945. doi: 10.1007/s10654-022-00899-w.
[24] Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005;97:142–146. doi: 10.1093/jnci/dji024.
[25] Taylor PR, Li B, Dawsey SM, Li J-Y, Yang CS, Guo W, et al. Prevention of esophageal cancer: The nutrition intervention trials in Linxian, China. Linxian Nutrition Intervention Trials Study Group. Cancer Res 1994;54:2029s–2031s.
[26] Xie P, Xia W, Lowe S, Zhou Z, Ding P, Cheng C, et al. High spicy food intake may increase the risk of esophageal cancer: A meta-analysis and systematic review. Nutr Res 2022;107:139–151.doi: 10.1016/j.nutres.2022.09.006.
[27] Zhong Y, Yang C, Wang N, Pan D, Wang S, Sun G. Hot tea drinking and the risk of esophageal cancer: A systematic review and meta-analysis. Nutr Cancer 2022;74:2384–2391.doi:10.1080/01635581.2021.2007963.
[28] Andrici J, Eslick GD. Hot food and beverage consumption and the risk of esophageal cancer: A meta-analysis. Am J Prev Med2015;49:952–960. doi: 10.1016/j.amepre.2015.07.023.
[29] Global Burden of Disease 2019 Cancer Collaboration, Kocarnik JM, Compton K, et al. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019[J]. JAMA Oncol. 2022, 8(3): 420-444.
[30] Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021[J]. CA Cancer J Clin, 2021, 71(1): 7-33.
[31] Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022[J]. CA Cancer J Clin, 2022, 72(1): 7-33.
[32] Zheng RS, Zhang SW, Zeng HM, et al. Cancer incidence and mortality in China, 2016[J]. J Natl Cancer Cent, 2022, 2(1): 1-9.

下载信息 [文件大小：607 KB 下载次数：次]

点击下载文件:EpidemiologicalTrendsandUpdatesonEsophagealCancer.pdf

Memo: